Search

1228867
1225602
1222005
1211849
1219355
Four women innovators to watch at UCT
Universities are conducive to innovation, as researchers and students dedicate themselves to the act of problem-solving through research. Over the past few years, UCT has been central to an array of practical innovations that have been implemented...
UCT Innovation by Numbers - 2017
The total income from IP commercialisation was R 3.78m and a total of 4 new UCT spin-off companies were formed, the highest ever in a year. 41 invention disclosures were received by RC...
UCT Exhibits at Innovation Bridge 2017
The time has come and gone for the Department of Science and Technology’s 2017 Innovation Bridge event.
Look into UCT’s Technology Innovation Activities through the Glass Pipeline
In response to comments from various stakeholders about the need to have a sense of the projects in the university’s pipeline, RC...
Electronic Lab Notebooks
RCI has produced hard copy laboratory notebooks a number of years, but especially in certain research areas an electronic notebook is now preferable.

News

Friday, 16 November 2018
Using computers to improve lives

The University of Cape Town’s (UCT) Department of Computer Science is set to enjoy a major boost with the naming of Dr Melissa Densmore, senior lecturer and Information and Communications Technologies for Development (ICT4D) staff member, as a recipient of the prestigious $500 000 National Academies Keck Futures Initiative (NAKFI) Challenge grant.

Publication Date:
Tuesday, October 30, 2018 - 12:30
Identifying novel biomarkers and therapeutic targets for cancer treatment

Over the past decade or so, there has been a massive shift in cancer research toward discovering more targeted therapeutic alternatives to chemotherapy and radiation. Subscribing to this approach, Professor Virna Leaner, head of the Division of Medical Biochemistry at UCT, and her group of researchers have dedicated their academic work to looking for novel cancer biomarkers that could serve as therapeutic targets.  

Publication Date:
Wednesday, October 17, 2018 - 15:00
Antibodies as tools in cancer treatment

The rising incidence of cancer in Africa coupled with the spiralling prices of leading therapies indicates that there is a great need for locally developed immune-oncology diagnostics and therapeutics. Following 20 years of work in the fields of medical biotechnology and immunotherapy in Germany, Professor Stefan Barth was recruited by the Department of Science and Technology/National Research Foundation’s South African Research Chair (SARChI) in 2015 to lead the Tier 1 Chair in Cancer Biotechnology at UCT.

Publication Date:
Wednesday, October 17, 2018 - 14:00
Student Entrepreneurship Week Events Feedback

RC&I hosted two events for Student Entrepreneurship Week (SEW) 2018 on 29 August. The highlight of these events was the launch of the UCT Innovation Ecosystem Map which clearly represents the spatial arrangement of incubators, accelerators and UCT Spin-Off companies relative to each other.

Publication Date:
Tuesday, October 16, 2018 - 15:15

Pages